AstraZeneca Sues Osmotic Over Seroquel ANDA

Law360, New York (September 14, 2010, 12:03 PM EDT) -- AstraZeneca Pharmaceuticals LP has sued Osmotica Pharmaceutical Corp., marking the drug giant's latest effort to stop a rival from coming out with a generic version of schizophrenia treatment Seroquel XR.

Osmotica's version of the drug would infringe a patent held by AstraZeneca, according to a complaint filed Monday in the U.S. District Court for the Eastern District of North Carolina.

Wilmington, N.C.-based Osmotica filed an abbreviated new drug application with the U.S. Food and Drug Administration seeking to market a generic version of Seroquel XR before...
To view the full article, register now.